Bide Pharmatech Co. Ltd. A (688073) — Financial Flexibility Index

Latest as of December 2025: 0.11x

Bide Pharmatech Co. Ltd. A (688073) has a Financial Flexibility Index of 0.11x as of December 2025. Free cash flow of CN¥52.61 Million (operating CF CN¥28.32 Million minus capex CN¥24.28 Million) represents 0% of total liabilities (CN¥471.40 Million). Also explore 688073 net assets growth trend to track the company's year-over-year net asset growth rate.

Financial Flexibility Index

0.11x
Free Cash Flow / Total Liabilities

Free Cash Flow

CN¥52.61 Million
Operating CF − Capex

Total Liabilities

CN¥471.40 Million
CNY

Capital Expenditures

CN¥24.28 Million
CNY

Bide Pharmatech Co. Ltd. A Financial Flexibility Index (2020–2025)

Historical Financial Flexibility Index trend for Bide Pharmatech Co. Ltd. A across 6 annual periods. Check Bide Pharmatech Co. Ltd. A (688073) asset resilience to evaluate the company's liquid asset resilience ratio.

Annual Financial Flexibility Index for Bide Pharmatech Co. Ltd. A (2020–2025)

Year-by-year free cash flow to debt coverage for Bide Pharmatech Co. Ltd. A. For the full company profile including market capitalisation, see Bide Pharmatech Co. Ltd. A (688073) market capitalisation.

Year Flexibility Index Free Cash Flow (CNY) Operating CF Total Liabilities YoY Change
2025 0.11x CN¥52.61 Million CN¥28.32 Million CN¥471.40 Million ▼ -82.3%
2024 0.63x CN¥246.66 Million CN¥158.31 Million CN¥390.91 Million ▲ +5464.4%
2023 0.01x CN¥3.69 Million CN¥-57.39 Million CN¥325.49 Million ▼ -95.3%
2022 0.24x CN¥68.28 Million CN¥29.87 Million CN¥283.05 Million ▲ +287.5%
2021 -0.13x CN¥-35.68 Million CN¥-64.88 Million CN¥277.27 Million ▼ -152.1%
2020 0.25x CN¥41.37 Million CN¥3.65 Million CN¥167.64 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities